Maridea Wealth Management LLC Makes New $2.75 Million Investment in HealthEquity, Inc. $HQY

Key Points

• Maridea Wealth Management initiated a $2.75 million position in HealthEquity during the second quarter by purchasing 30,479 shares. Institutional investors collectively own 99.55% of the company.
• HealthEquity reported quarterly earnings of $1.24 per share, beating estimates by $0.13, while revenue rose 7.2% year over year to $354.64 million.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $110.93, compared with the stock’s recent price of $104.73.

Maridea Wealth Management LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 30,479 shares of the company's stock, valued at approximately $2,753,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in HQY. William Blair Investment Management LLC purchased a new stake in HealthEquity in the fourth quarter worth $169,956,000. Wasatch Advisors LP raised its holdings in HealthEquity by 10.5% in the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company's stock worth $719,014,000 after purchasing an additional 757,801 shares in the last quarter. Norges Bank purchased a new position in HealthEquity during the fourth quarter valued at $66,927,000. AQR Capital Management LLC lifted its position in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company's stock valued at $116,016,000 after buying an additional 661,795 shares during the period. Finally, Millennium Management LLC boosted its holdings in shares of HealthEquity by 151.5% during the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company's stock valued at $87,173,000 after buying an additional 573,283 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the firm's stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president directly owned 52,244 shares in the company, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company's stock, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on HQY shares. Citizens Jmp increased their price target on shares of HealthEquity from $110.00 to $111.00 and gave the stock a "market outperform" rating in a research note on Monday, June 1st. KeyCorp reissued an "overweight" rating on shares of HealthEquity in a research report on Tuesday, May 26th. BTIG Research boosted their price objective on shares of HealthEquity from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Friday, July 24th. Wall Street Zen cut shares of HealthEquity from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Finally, Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research note on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $110.93.

HealthEquity Trading Down 0.8%

NASDAQ HQY opened at $104.73 on Friday. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $107.62. The stock has a market cap of $8.76 billion, a P/E ratio of 39.22, a P/E/G ratio of 1.76 and a beta of 0.21. The stock's fifty day moving average price is $95.15 and its 200-day moving average price is $86.51. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity's revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source